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Equine anaplasmosis is a vector-borne disease
transmitted by ticks belonging to the Ixodes genus,
especially I. ricinus in metropolitan France. The
causative agent is a bacterium of the Anaplasma-
taceae family: Anaplasma phagocytophilum [1]. The
clinical presentation ranges from asymptomatic,
where horses are infected but do not show
outward signs of disease, to others that present
with signs consistent with a febrile illness (fever,
lethargy, anorexia), icterus, ataxia and oedema of
members. The ﬁrst clinical case was described in
the USA and then in Europe (predominately in
France in 2000) [2]. The aspects in veterinary
public health are important: human cases were
recognised in 1994 in the USA and in Europe in
1995 [3]. The epidemiology of equine anaplasmo-
sis is quite unknown: the reservoir has not been
identiﬁed and the cases’ repartition has to be
detailed.
The goal of this study is to assess the preva-
lence of Anaplasma in equines in France and
Africa using a serological method and to detect
eventual risk factors.
Blood samples were obtained on 570 horses in
13 sites in metropolitan France (408), in French
Guyana (49) and in ﬁve African countries (Ivory
Coast, Chad, Gabon, Congo (DR) and Djibouti)
(113). On each site, if the number of horses was
less than 30 all horses were tested, otherwise only
30 subjects were selected.
The blood samples were tested using an ELISA
Dot-Blot method (SNAP 4Dx, IDEXX Laborato-
ries Inc., Westbrook, ME, USA), allowing detec-
tion of both Ig M and Ig G. The percentages were
compared using the chi-squared test (a = 5%).
The results are shown in Table 1. None of the
horses tested from Africa, French Guyana or in
the southern France group had antibodies to
A. phagocytophilum. The seroprevalences in the
centre-western and eastern regions in France were
16.0% and 20.1%, respectively. Among the north-
ern France group (included the centre-western
and eastern France groups), 23.1% of females and
15.8% of males tested positive; 24.5% of ponies
and 16.8% of horses; 14.3% of 0–5 year old
subjects, 18.6% of 6–10 year old ones, 17.7% of
11–15 year old ones, 21.4% of 16–20 year old ones
and 14.3% of 21–25 year old ones. The prevalenc-
es in Africa, French Guyana and metropolitan
France were statistically different (p< 0.01). In
metropolitan France, a signiﬁcant difference
appeared between the northern and the southern
groups (p< 0.00001). The difference between the
centre-western and eastern groups wasn’t statis-
tically signiﬁcant. Among the northern group, no
risk factors were identiﬁed (sex, pony vs. horse
and ⁄ or age). At the site of Metz, the ponies had
higher infection rate than the adult horses
(p < 0.0001).
The vector of equine anaplasmosis in metro-
politan France is a hard tick, Ixodes ricinus. Its
preferred environment is humid areas near
woods or prairies. The ticks don’t constitute the
reservoir of the disease. This reservoir has not
been determined. Our study conﬁrms that the
positive horses are only detected in the preferen-
tial areas of the vector (northern France). This
ﬁnding is in contrast to other studies that have
shown the existence of the pathogen in the south
(11.3% in Leblond et al. in 2005) [4]. The differ-
ences may be explained by the poor speciﬁcity of
the serological method and the fact that different
geographic regions in southern France were
evaluated.
The commercial kit used in this study is
recommended by the manufacturer as a canine
Corresponding author and reprint requests: B. Davoust,
Direction Re´gionale du Service de Sante´ des Arme´es de
Toulon, BP 80, 83800 Toulon Arme´es, France
E-mail: bernard.davoust@mageos.com
No conﬂicts of interest declared.
 2009 The Authors
Journal Compilation  2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15 (Suppl. 2), 68–69
test. However, because the assay uses antigen-
speciﬁc conjugate, it can work with samples
irrespective of the species from which the samples
are derived. We used the SNAP 4Dx to assess
the prevalence of antibodies to A. phagocytophilum
in horses. One interesting ﬁnding is that the
ponies were more infected than the horses. These
results may be explained by their higher rate of
infestation by ticks and by their lifestyle, which
subjects them to longer duration of time spent
outside.
Our results show that equine anaplasmosis
should be included in northern France in the
differential diagnosis of unknown origin fevers.
Other tick-borne diseases may present similar
clinical presentations, such as babesiosis and
borreliosis. Complementary examinations are
available to conﬁrm the infection by A. phagocy-
tophilum: blood smears or PCR.
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Table 1. Seroprevalence of equine anaplasmosis in France
and in sub-Saharan Africa
Location
In-clinic ELISA
(Snap 4Dx)Country Region City
Metropolitan
France
55 ⁄ 408 (13.5%)
Centre-west 23 ⁄ 144 (16%)
Coe¨tquidan 4 ⁄ 20 (20%)
Fontainbleau 9 ⁄ 49 (18.4%)
Olivet 4 ⁄ 19 (21%)
Saumur 3 ⁄ 31 (9.7%)
Tours 3 ⁄ 25 (12%)
East 32 ⁄ 159 (20.1%)
Mourmelon 7 ⁄ 47 (14.9%)
Dieuze 3 ⁄ 23 (13%)
Metz 8 ⁄ 24 (33.3%)
Verdun 6 ⁄ 40 (15%)
Bitche 8 ⁄ 25 (32%)
South-east 0 ⁄ 105 (0%)
Marseille 0 ⁄ 30 (0%)
Draguignan 0 ⁄ 34 (0%)
Orange 0 ⁄ 41 (0%)
French Guyana 0 ⁄ 49 (0%)
Africa 0 ⁄ 113 (0%)
Ivory Coast 0 ⁄ 25 (0%)
Gabon 0 ⁄ 38 (0%)
Chad 0 ⁄ 20 (0%)
Congo (DR) 0 ⁄ 20 (0%)
Djibouti 0 ⁄ 10 (0%)
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